CSF1R and neoplasm: We next evaluated in vivo anti-tumor activity of pCAR-M/34 T cells against a challenging Karpas (K)299 anaplastic lymphoma xenograft that undergoes rapid lymphatic dissemination (Figures 4A and 4B) and expresses low levels of the M-CSFR (Figure 4C).